Literature DB >> 6292047

The expression of Streptomyces and Escherichia coli drug-resistance determinants cloned into the Streptomyces phage phi C31.

K F Chater, C J Bruton, A A King, J E Suarez.   

Abstract

Lysogens obtained by infecting Streptomyces albus G with a phi C31-pBR322 chimaeric prophage or its delta W12 deletion derivative had increased tetracycline resistance. The ability of the delta W12 derivative to transduce tetracycline resistance was inactivated by inserting a viomycin resistance determinant (vph) into the BamHI site of the pBR322 tet gene, and restored by excising the vph gene. Another deletion mutant (delta W17) of the chimaera, carrying an intact tet gene, was normally unable to transduce tetracycline resistance. This inability was correlated with the finding, by Southern hybridisation analysis, that the att site required for insertion of phi C31 prophage into the host chromosome was located within the delta W17 deletion. Use of phi C31 lysogenic recipient permitted the integration of the att-deleted phage, presumably by homologous recombination, giving tetracycline-resistant double lysogens. This technique was extended to S. coelicolor A3(2) in the detection of derivatives of the att-deleted phage into which a thiostrepton-resistance determinant (tsr) had been inserted in vitro. Phage released from double lysogens were mainly recombinants. One such recombinant is a PstI vector for DNA cloning, able to accommodate up to 6 kb of introduced DNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292047     DOI: 10.1016/0378-1119(82)90185-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  48 in total

1.  Mathematical analysis of growth and interaction dynamics of streptomycetes and a bacteriophage in soil.

Authors:  N J Burroughs; P Marsh; E M Wellington
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

2.  Characterization of the pathway-specific positive transcriptional regulator for actinorhodin biosynthesis in Streptomyces coelicolor A3(2) as a DNA-binding protein.

Authors:  P Arias; M A Fernández-Moreno; F Malpartida
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

3.  Genomewide insertional mutagenesis in Streptomyces coelicolor reveals additional genes involved in morphological differentiation.

Authors:  A M Gehring; J R Nodwell; S M Beverley; R Losick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

4.  Phase variation in the phage growth limitation system of Streptomyces coelicolor A3(2).

Authors:  Paul Sumby; Margaret C M Smith
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

5.  Genetic analysis of absB, a Streptomyces coelicolor locus involved in global antibiotic regulation.

Authors:  T Adamidis; W Champness
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

6.  Global negative regulation of Streptomyces coelicolor antibiotic synthesis mediated by an absA-encoded putative signal transduction system.

Authors:  P Brian; P J Riggle; R A Santos; W C Champness
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

7.  Structural analysis of the actinophage phi C31 attachment site.

Authors:  H Rausch; M Lehmann
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

8.  Streptomyces coelicolor A3(2) lacks a genomic island present in the chromosome of Streptomyces lividans 66.

Authors:  Xiufen Zhou; Xinyi He; Aiying Li; Fang Lei; Tobias Kieser; Zixin Deng
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

9.  The Streptomyces coelicolor developmental transcription factor sigmaBldN is synthesized as a proprotein.

Authors:  Maureen J Bibb; Mark J Buttner
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

10.  Transcriptional regulation of Streptomyces coelicolor pathway-specific antibiotic regulators by the absA and absB loci.

Authors:  D J Aceti; W C Champness
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.